In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating -3.89% over the last five trades and -15.61% over the past 30 trades. This represents a notable shift from ...
Aclarion, Inc. ( (ACON) ) just unveiled an update. Aclarion, Inc. announced the pricing of a registered direct offering of ...
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...
EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market 03.01.2025 / 22:15 CET/CEST The issuer is solely ...
Aclarion, Inc. (NASDAQ: ACON) recently disclosed the outcomes of its 2024 Annual Meeting of Stockholders in a Form 8-K filing with the Securities and Exchange Commission. The meeting, which took place ...
Aclarion, Inc. announced the termination of its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC effective immediately. This decision halts the company’s ability to sell ...
Aclarion, Inc. announced the termination of its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC effective immediately. This decision halts the company’s ability to ...
Zacks.com on MSN7d
Aclarion (ACON) Upgraded to Buy: Here's What You Should KnowAclarion (ACON) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BROOMFIELD, CO - (NewMediaWire) - January 3, 2025 - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW ...
Aclarion, Inc., a Delaware-incorporated medical laboratories service provider, announced the results of its annual stockholders meeting held on December 31, 2024. The meeting saw the election of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback